Supplemental feeding of a gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, alleviates spontaneous atopic dermatitis and modulates intestinal microbiota in NC/nga mice

International Journal of Food Sciences and Nutrition

Volumn 68, Issue 8, 2017, Pages 941-951

  Kaikiri, Hiroko ^a   Miyamoto, Junki ^a   Kawakami, Takahiro ^a   Park, Si Bum ^b   Kitamura, Nahoko ^b   Kishino, Shigenobu ^b   Yonejima, Yasunori ^c   Hisa, Keiko ^c   Watanabe, Jun ^d   Ogita, Tasuku ^d   Ogawa, Jun ^b   Tanabe, Soichi ^a   Suzuki, Takuya ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Nitto Pharmaceutical Industries Ltd   (Japan)

^d NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

Author keywords

10 Hydroxy cis 12 octadecenoic acid; atopic dermatitis; gut microbial metabolite; intestinal microbiota

Indexed keywords

10-HYDROXY-12-OCTADECENOIC ACID; CYTOKINE; IMMUNOGLOBULIN A; LINOLEIC ACID; OLEIC ACID;

ANIMAL; ANIMAL BEHAVIOR; ANIMAL FOOD; ATOPIC DERMATITIS; CHEMICAL STRUCTURE; CHEMISTRY; DIET; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; FECES; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; INTESTINE FLORA; METABOLISM; MOUSE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VETERINARY;

ANIMAL FEED; ANIMALS; BEHAVIOR, ANIMAL; CYTOKINES; DERMATITIS, ATOPIC; DIET; DIETARY SUPPLEMENTS; FECES; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN A; INFLAMMATION; LINOLEIC ACID; MICE; MOLECULAR STRUCTURE; OLEIC ACIDS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 85018673674     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.1080/09637486.2017.1318116     Document Type: Article

References (34)

1. Bergamo P, Luongo D, Miyamoto J, Cocca E, Kishino S, Ogawa J, Tanabe S, Rossi M., 2014. Immunomodulatory activity of a gut microbial metabolite of dietary linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, associated with improved antioxidant/detoxifying defences. J Funct Food. 11:192–202.
2. Bergamo P, Gogliettino M, Palmieri G, Cocca E, Maurano F, Stefanile R, Balestrieri M, Mazzarella G, David C, Rossi M., 2011. Conjugated linoleic acid protects against gliadin-induced depletion of intestinal defenses. Mol Nutr Food Res. 55:S248–S256.
3. Blutt SE, Miller AD, Salmon SL, Metzger DW, Conner ME., 2012. IgA is important for clearance and critical for protection from rotavirus infection. Mucosal Immunol. 5:712–719.
4. Correa da Rosa J, Malajian D, Shemer A, Rozenblit M, Dhingra N, Czarnowicki T, Khattri S, Ungar B, Finney R, Xu H, et al. 2015. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin. J Allergy Clin Immunol. 135:712–720.
5. De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, Berger AE, Zhang K, Vidyasagar S, Yoshida T, et al. 2011. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 127:773–786.
6. Drago L, Toscano M, De Vecchi E, Piconi S, Iemoli E., 2012. Changing of fecal flora and clinical effect of L. salivarius LS01 in adults with atopic dermatitis. J Clin Gastroenterol. 46:S56–S63.
7. Drell T, Larionova A, Voor T, Simm J, Julge K, Heilman K, Tillmann V, Štšepetova J, Sepp E., 2015. Differences in gut microbiota between atopic and healthy children. Curr Microbiol. 71:177–183.
8. Fujii M, Nakashima H, Tomozawa J, Shimazaki Y, Ohyanagi C, Kawaguchi N, Ohya S, Kohno S, Nabe T., 2013. Deficiency of n-6 polyunsaturated fatty acids is mainly responsible for atopic dermatitis-like pruritic skin inflammation in special diet-fed hairless mice. Exp Dermatol. 22:272–277.
9. Furuya Y, Kirimanjeswara GS, Roberts S, Metzger DW., 2013. Increased susceptibility of IgA-deficient mice to pulmonary Francisella tularensis live vaccine strain infection. Infect Immun. 81:3434–3441.
10. Galli SJ, Tsai M., 2012. IgE and mast cells in allergic disease. Nat Med. 18:693–704.
11. Hamilton RG., 2010. Clinical laboratory assessment of immediate-type hypersensitivity. J Allergy Clin Immunol. 125:S284–S296.
12. Inoue R, Nishio A, Fukushima Y, Ushida K., 2007. Oral treatment with probiotic Lactobacillus johnsonii NCC533 (La1) for a specific part of the weaning period prevents the development of atopic dermatitis induced after maturation in model mice, NC/Nga. Brit J Dermatol. 156:499–509.
13. Jaudszus A, Krokowski M, Mockel P, Darcan Y, Avagyan A, Matricardi P, Jahreis G, Hamelmann E., 2008. Cis-9,trans-11-conjugated linoleic acid inhibits allergic sensitization and airway inflammation via a PPARgamma-related mechanism in mice. J Nutr. 138:1336–1342.
14. Kalesnikoff J, Huber M, Lam V, Damen JE, Zhang J, Siraganian RP, Krystal G., 2001. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity. 14:801–811.
15. Kiiski V, Karlsson O, Remitz A, Reitamo S., 2015. High serum total IgE predicts poor long-term outcome in atopic dermatitis. Acta Derm Venereol. 95:943–947.
16. Kikuchi Y, Yoshida H, Ogita T, Okita K, Fukudome S, Suzuki T, Tanabe S., 2015. In vivo dose response and in vitro mechanistic analysis of enhanced immunoglobulin A production by Lactobacillus plantarum AYA. Biosci Microbiota Food Health. 34:53–58.
17. Kishino S, Takeuchi M, Park SB, Hirata A, Kitamura N, Kunisawa J, Kiyono H, Iwamoto R, Isobe Y, Arita M, et al. 2013. Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition. Proc. Natl Acad Sci USA. 110:17808–17813.
18. Kukkonen K, Kuitunen M, Haahtela T, Korpela R, Poussa T, Savilahti E., 2010. High intestinal IgA associates with reduced risk of IgE-associated allergic diseases. Pediatr Allergy Immunol. 21:67–73.
19. Martinasso G, Saracino S, Maggiora M, Oraldi M, Canuto RA, Muzio G., 2010. Conjugated linoleic acid prevents cell growth and cytokine production induced by TPA in human keratinocytes NCTC 2544. Cancer Lett. 287:62–66.
20. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C., 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol. 9:461–466.
21. Miyamoto J, Mizukure T, Park SB, Kishino S, Kimura I, Hirano K, Bergamo P, Rossi M, Suzuki T, Arita M, et al. 2015. A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway. J Biol Chem. 290:2902–2918.
22. Nagashio Y, Matsuura Y, Miyamoto J, Kometani T, Suzuki T, Tanabe S., 2013. Hesperidin inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice by suppressing Th17 activity. J Funct Foods. 5:1633–1641.
23. Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A., 2002. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J. Allergy Clin. Immunol. 110:617–623.
24. Rasband WS., 1997–2012. ImageJ software. Bethesda, Maryland, USA: U.S. National Institutes of Health. Available from: http://rsb.info.nih.gov/ij/
25. Segawa S, Hayashi A, Nakakita Y, Kaneda H, Watari J, Yasui H., 2008. Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates the development of dermatitis and inhibits immunoglobulin E production in atopic dermatitis model NC/Nga mice. Biol Pharm Bull. 31:884–889.
26. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS., 1999. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest. 103:1103–1111.
27. Suarez-Farinas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong C, Krueger JG, Guttman-Yassky E., 2013. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J. Allergy Clin. Immunol. 132:361–370.
28. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y., 1997. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 159:1739–1745.
29. Tanabe S, Hochi S., 2010. Oral administration of a galactooligosaccharide preparation inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice. Int J Mol Med. 25:331–336.
30. Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R, Leunissen JA., 2007. Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res. 35:W71–W74.
31. Viljanen M, Kuitunen M, Haahtela T, Juntunen-Backman K, Korpela R, Savilahti E., 2005. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol. 16:65–71.
32. Ward JH., 1963. Hierarchical Grouping to Optimize an Objective Function. J Am Stat Assoc 58: 236–244.
33. Watanabe J, Fujiwara R, Sasajima N, Ito S, Sonoyama K., 2010. Administration of antibiotics during infancy promoted the development of atopic dermatitis-like skin lesions in NC/Nga mice. Biosci Biotech Bioch. 74:358–363.
34. Zenhom M, Hyder A, Kraus-Stojanowic I, Auinger A, Roeder T, Schrezenmeir J., 2011. PPARgamma-dependent peptidoglycan recognition protein 3 (PGlyRP3) expression regulates proinflammatory cytokines by microbial and dietary fatty acids. Immunobiology. 216:715–724.